T-CELLS MIGRATE TO TUMOR SITES AFTER EXTRACORPOREAL INTERLEUKIN-2 STIMULATION AND REINFUSION IN A PATIENT WITH METASTATIC MELANOMA
T-CELLS MIGRATE TO TUMOR SITES AFTER EXTRACORPOREAL INTERLEUKIN-2 STIMULATION AND REINFUSION IN A PATIENT WITH METASTATIC MELANOMA
复制标题
DOI:
10.1111/j.1365-2133.1993.tb00198.x
复制
发表时间:
1993-04-01
影响因子:
10.3
通讯作者:
BURG, G
中科院分区:
文献类型:
--
作者:
DUMMER, R;BECKER, JC;BURG, G
Peripheral blood mononuclear cells (PBMC) were taken by leukapheresis from a patient with melanoma skin metastases and stimulated in vitro using 1000 IU recombinant interleukin 2 (IL-2)/ml to generate lymphokine-activated killer cells (LAK cells). Two-colour immunofluorescence analysis demonstrated an IL-2-induced up-regulation of CD25 on natural killer cells (CD56+) as well as on T lymphocytes (CD3-). After radiolabelling with indium-111, the cells were reinfused. Gamma-camera imaging revealed an enrichment at the tumour sites. Immunostaining of tumour tissue taken before and after scintigraphy demonstrated CD25- T lymphocytes (CD2+, CD3+). but no natural killer cells (CD16+, CD56+) infiltrating the metastases.LAK cell enrichment at melanoma metastases in vivo did not involve natural killer cells, but was characterized by increased numbers of activated T lymphocytes in this patient.